Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

A chemiluminescent-western blot assay for quantitative detection of Plasmodium falciparum circumsporozoite protein.

Kumar S, Zheng H, Sangweme DT, Mahajan B, Kozakai Y, Pham PT, Morin MJ, Locke E, Kumar N.

J Immunol Methods. 2013 Apr 30;390(1-2):99-105. doi: 10.1016/j.jim.2013.02.001. Epub 2013 Feb 8.

PMID:
23399449
2.

A slot blot immunoassay for quantitative detection of Plasmodium falciparum circumsporozoite protein in mosquito midgut oocyst.

Kumar S, Zheng H, Deng B, Mahajan B, Grabias B, Kozakai Y, Morin MJ, Locke E, Birkett A, Miura K, Long C.

PLoS One. 2014 Dec 22;9(12):e115807. doi: 10.1371/journal.pone.0115807. eCollection 2014.

3.

Western blot assay for quantitative and qualitative antigen detection in vaccine development.

Kumar S, Zheng H, Mahajan B, Kozakai Y, Morin M, Locke E.

Curr Protoc Microbiol. 2014 May 1;33:18.4.1-11. doi: 10.1002/9780471729259.mc1804s33.

PMID:
24789597
4.

Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum.

Clement F, Dewar V, Van Braeckel E, Desombere I, Dewerchin M, Swysen C, Demoitié MA, Jongert E, Cohen J, Leroux-Roels G, Cambron P.

Malar J. 2012 Nov 22;11:384. doi: 10.1186/1475-2875-11-384.

5.

Poly(I:C) is an effective adjuvant for antibody and multi-functional CD4+ T cell responses to Plasmodium falciparum circumsporozoite protein (CSP) and αDEC-CSP in non human primates.

Tewari K, Flynn BJ, Boscardin SB, Kastenmueller K, Salazar AM, Anderson CA, Soundarapandian V, Ahumada A, Keler T, Hoffman SL, Nussenzweig MC, Steinman RM, Seder RA.

Vaccine. 2010 Oct 21;28(45):7256-66. doi: 10.1016/j.vaccine.2010.08.098. Epub 2010 Sep 21.

6.

Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).

Udhayakumar V, Saekhou A, Fang S, Jue D, Wohlhueter RM, Lal AA.

Vaccine. 1998 May-Jun;16(9-10):982-8.

PMID:
9682348
7.
8.

Malaria vaccine candidate antigen targeting the pre-erythrocytic stage of Plasmodium falciparum produced at high level in plants.

Voepel N, Boes A, Edgue G, Beiss V, Kapelski S, Reimann A, Schillberg S, Pradel G, Fendel R, Scheuermayer M, Spiegel H, Fischer R.

Biotechnol J. 2014 Nov;9(11):1435-45. doi: 10.1002/biot.201400350. Epub 2014 Oct 10.

PMID:
25200253
9.

A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.

Zhang M, Kaneko I, Tsao T, Mitchell R, Nardin EH, Iwanaga S, Yuda M, Tsuji M.

Malar J. 2016 Apr 12;15:201. doi: 10.1186/s12936-016-1248-z.

10.

Transgenic parasites stably expressing full-length Plasmodium falciparum circumsporozoite protein as a model for vaccine down-selection in mice using sterile protection as an endpoint.

Porter MD, Nicki J, Pool CD, DeBot M, Illam RM, Brando C, Bozick B, De La Vega P, Angra D, Spaccapelo R, Crisanti A, Murphy JR, Bennett JW, Schwenk RJ, Ockenhouse CF, Dutta S.

Clin Vaccine Immunol. 2013 Jun;20(6):803-10. doi: 10.1128/CVI.00066-13. Epub 2013 Mar 27.

11.

Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate.

Plassmeyer ML, Reiter K, Shimp RL Jr, Kotova S, Smith PD, Hurt DE, House B, Zou X, Zhang Y, Hickman M, Uchime O, Herrera R, Nguyen V, Glen J, Lebowitz J, Jin AJ, Miller LH, MacDonald NJ, Wu Y, Narum DL.

J Biol Chem. 2009 Sep 25;284(39):26951-63. doi: 10.1074/jbc.M109.013706. Epub 2009 Jul 24.

12.

A full-length Plasmodium falciparum recombinant circumsporozoite protein expressed by Pseudomonas fluorescens platform as a malaria vaccine candidate.

Noe AR, Espinosa D, Li X, Coelho-Dos-Reis JG, Funakoshi R, Giardina S, Jin H, Retallack DM, Haverstock R, Allen JR, Vedvick TS, Fox CB, Reed SG, Ayala R, Roberts B, Winram SB, Sacci J, Tsuji M, Zavala F, Gutierrez GM.

PLoS One. 2014 Sep 23;9(9):e107764. doi: 10.1371/journal.pone.0107764. eCollection 2014.

13.

A peptide-based Plasmodium falciparum circumsporozoite assay to test for serum antibody responses to pre-erythrocyte malaria vaccines.

Kostense S, Mommaas B, Hendriks J, Verhoeven M, Ter Haak M, Tirion F, Wiesken E, Pau MG, Radosevic K, Goudsmit J.

Clin Vaccine Immunol. 2011 May;18(5):776-82. doi: 10.1128/CVI.00547-10. Epub 2011 Mar 16.

14.

Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.

Nguyen TV, Sacci JB Jr, de la Vega P, John CC, James AA, Kang AS.

Malar J. 2009 Oct 23;8:235. doi: 10.1186/1475-2875-8-235.

15.

Live attenuated pre-erythrocytic malaria vaccines.

Keitany GJ, Vignali M, Wang R.

Hum Vaccin Immunother. 2014;10(10):2903-9. doi: 10.4161/21645515.2014.972764. Review.

16.

Characterization of murine monoclonal antibodies against a repetitive synthetic peptide from the circumsporozoite protein of the human malaria parasite, Plasmodium falciparum.

Del Giudice G, Tougne C, Renia L, Ponnudurai T, Corradin G, Pessi A, Verdini AS, Louis JA, Mazier D, Lambert PH.

Mol Immunol. 1991 Sep;28(9):1003-9.

PMID:
1922106
17.

T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites.

Nardin E, Munesinghe YD, Moreno A, Clavijo P, Calle MC, Edelman R, Davis J, Herrington D, Nussenzweig RS.

Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:223-7. Review.

18.

Quantitative Plasmodium sporozoite neutralization assay (TSNA).

Kumar KA, Oliveira GA, Edelman R, Nardin E, Nussenzweig V.

J Immunol Methods. 2004 Sep;292(1-2):157-64.

PMID:
15350520
19.

Restricted T-cell epitope diversity in the circumsporozoite protein from Plasmodium falciparum populations prevalent in Iran.

Zakeri S, Avazalipoor M, Mehrizi AA, Djadid ND, Snounou G.

Am J Trop Med Hyg. 2007 Jun;76(6):1046-51.

PMID:
17556609
20.

The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.

Epstein JE, Richie TL.

Curr Opin Infect Dis. 2013 Oct;26(5):420-8. doi: 10.1097/QCO.0000000000000002. Review.

PMID:
23982233

Supplemental Content

Support Center